Skip to content
Screener

10x Genomics, Inc. TXG Q1 2025 earnings

Reported May 8, 2025 · After market close

Revenue$154.9MBeat by $9.6M
EPS-$0.36Beat by $0.09
Revenue estimate$145.3M
EPS estimate-$0.45

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$147.3M
EPS estimate-$0.27

Financials

Q1 2025

Income statement

See full
Revenue$154.9M+9.8%
Gross profit$105.4M+13.5%
Operating income-$39.3M+36.0%
Net income-$34.4M+42.7%
EPS (diluted)-$0.28+44.0%

Balance sheet

See full
Cash & equivalents$377.1M+6.0%
Total debt$80.1M-13.1%
Total equity$706.9M-1.7%
Total assets$903.4M-2.1%

Cash flow

See full
Operating cash flow$34.4M+318%
CapEx$1.9M-34.9%
Free cash flow$32.5M+274%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$1.07B-76.2%
Enterprise value$770.71M-81.7%
P/S1.7×-5.5×

Profitability

See full
Gross margin68.4%+3.8pp
Operating margin-27.6%-7.5pp
Net margin-25.1%-7.2pp

Returns & leverage

See full
Return on equity-22%-5.9pp
Debt / equity0.1×0.0×
Current ratio5.4×+0.2×

Segments

By product

See full
Products and services revenue$137.8M-2.3%
License and royalty revenue$17.1M+1,705,900%
Spatial$8.9M-49.4%
Services$7.7M+46.7%
Single Cell$5.9M—

By geography

See full
Europe, Middle East and Africa$31.9M-8.1%
Asia-Pacific (excluding China)$15.5M+22.0%
Americas (excluding United States)$3.8M-6.0%

FAQ

When did 10x Genomics, Inc. report Q1 2025 earnings?
10x Genomics, Inc. (TXG) reported Q1 2025 earnings on May 8, 2025 after market close.
What were 10x Genomics, Inc.'s Q1 2025 revenue and EPS?
10x Genomics, Inc. reported revenue of $154.9M and eps of $-0.36 for Q1 2025.
Did 10x Genomics, Inc. beat estimates in Q1 2025?
Revenue beat the consensus estimate of $145.3M by $9.6M. EPS beat the consensus estimate of $-0.45 by $0.09.
How did 10x Genomics, Inc.'s Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 9.8% from $141.0M a year earlier and eps grew 28.0% from $-0.50.
Where can I find 10x Genomics, Inc.'s Q1 2025 SEC filings?
You can read the 8-K earnings release (0001770787-25-000031) and the 10-Q periodic report (0001770787-25-000032) directly on SEC EDGAR. The filing index links above go to sec.gov.